Kura Oncology (KURA) Short Interest
Nasdaq • KURA • US50127T1097
As of Oct 26, 2026, ORTEX estimated 20% of free float sold short, 8.7 days to cover, cost to borrow 0.36%. Sign up for live short interest data.
Nasdaq • KURA • US50127T1097
As of Oct 26, 2026, ORTEX estimated 20% of free float sold short, 8.7 days to cover, cost to borrow 0.36%. Sign up for live short interest data.
This page tracks how heavily Kura Oncology (Nasdaq:KURA) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Kura Oncology (Nasdaq: KURA) has a market capitalization of $673.43M. Last close $7.57 (as of 2026-11-11); 52-week range $6.75 to $13.90. ORTEX data as of 2026-10-26: short interest was 20.02% of free float, 8.7 days to cover and the average cost to borrow was 0.36%. Sign up for live short interest data.